Newly-released Pulse Electromagnetic Field Therapy Devices Market industry analysis report by Future Market Insights shows that global sales of the Pulse Electromagnetic Field Therapy Devices Market in 2021 were held at US$ 416.6 million. With 8.6%, the projected market growth from 2022 to 2032 is expected to be higher than the historical growth. The market through the Low-Frequency segment is expected to gross the highest revenue, accounting for a CAGR of nearly 8.8% from 2022 to 2032.
| Attribute | Details |
|---|---|
| Global Pulse Electromagnetic Field Therapy Devices Market (2022) | US$ 452.4 million |
| Global Pulse Electromagnetic Field Therapy Devices Market (2032) | US$ 1 billion |
| Global Pulse Electromagnetic Field Therapy Devices Market CAGR (2022 to 2032) | 8.6% |
| USA Pulse Electromagnetic Field Therapy Devices Market CAGR (2022 to 2032) | 8% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Pulse Electromagnetic Field Therapy Devices Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Pulse Electromagnetic Field Therapy Devices Market industry increased at around 7.8% CAGR. Countries such as the USA, United Kingdom, China, Japan, and, South Korea held a significant share of the global market.
PEMF (pulsed electromagnetic field) therapy devices are non-invasive and have no known negative effects. PEMF therapy is a treatment option for a variety of musculoskeletal problems. The FDA has approved PEMF devices for the treatment of non-union fractures as well as post-operative osteoarthritis, plantar fasciitis, discomfort, and edema.
These devices also have a number of advantages, including the reduction of chronic and acute pain associated with a variety of connective tissues, such as bone, tendon, ligament, and cartilage injury, as well as the control of edema and inflammation. As a result, the advantages of these devices are expected to drive market expansion.
The market is expected to rise due to an increase in the global elderly population and increased awareness of pulse electromagnetic field (PEMF) therapy devices. The market position is projected to be secured by technological improvements including the development of narrow, downsized PEMF therapeutic devices employing sophisticated materials. The addition of telemedicine is likely to broaden the range of applications for these devices.
Severe spinal injuries, as well as delayed union and non-union fractures, are the most common outcomes of road accidents and trauma, necessitating surgical intervention. During the treatment of failed spinal fusions, delayed unions, fracture non-union, and new fractures, PEMF therapy devices stimulate bone repair.
The International Osteoporosis Foundation estimates that osteoporosis causes 8.9 million fractures per year. Furthermore, approximately 1.6 million hip fractures occur globally each year, with this figure expected to rise to between 4.5 and 6.3 million by 2050. As a result, the demand for PEMF therapy devices is likely to rise as the number of instances of osteoporosis rises.
The surge in the number of fractures due to falls, accidents, and sports injuries and Poor conditions of roads in various countries are some of the factors responsible for the growth of the market. Fractures caused by sports injuries, accidents, falls from a certain height, and symptoms such as arthritis, knee discomfort, and joint pain affect a major section of people around the world.
According to WHO figures, around 1.3 million people die each year as a result of traffic accidents. Furthermore, low- and middle-income countries account for the majority of worldwide traffic fatalities. Poorly maintained roads can result in a variety of injuries and pain in various body areas.
Potholes, uneven roads, broken surfaces, and road cracking can all cause injury to pedestrians, necessitating medical attention. Furthermore, governments' lack of focus on improving road infrastructure raises the risk of accidents and other injuries that can cause significant pain, raising healthcare expenses for individuals.
Interventional Orthopaedics of Atlanta is promoting PEMF therapy, an orthopedic clinic in Atlanta, Georgia, for the treatment of chronic tiredness symptoms, osteoporosis, and poor wound healing. The market for pulse electromagnetic field therapy devices in the United States is growing as a result of these discoveries.
PEMF technology is known for generating energy in the body's cells without requiring invasive surgery. For enterprises in the pulse electromagnetic field (PEMF) therapeutic equipment industry, such advantages translate into value-grab opportunities. PEMF therapy boosts the body's natural function by amplifying the body's natural energy. This therapy aids in the improvement of sports performance as well as the speedier recovery of injuries.
Principal Consultant
Because electromagnetic therapies cause a wide range of interactions within the body, some patients have reported discomfort during their first sessions. As a result, these occurrences occur seldom during the initial stages of treatment. Mild side effects are more common with whole-body treatments and, in rare situations, local therapies.
PEMF side effects are small and transitory, and they normally go away after the therapy is continued. Furthermore, people with electromagnetic hypersensitivity are more likely to have these side effects. Patients may experience overreactions because PEMF therapy has the power to modify biological systems and excite cells or tissues.
United States remains the most dominant country in the Pulse Electromagnetic Field Therapy Market having the expected largest market share of US$ 358.3 million by 2032. The demand for PEMF therapy devices in the United States is expected to rise as the number of individuals suffering from osteoporosis and osteoarthritis rises. Furthermore, the growing shift to minimally invasive procedures is expected to boost regional growth. In addition, the presence of a well-developed healthcare system in the United States is expected to stimulate the demand.
The market in the United Kingdom is projected to reach a valuation of US$ 48 million by 2032. With a CAGR of 9.8% from 2022 to 2032, the market is expected to gross an absolute dollar opportunity of US$ 29 million during the forecast period.
In Japan, the market is expected to reach US$ 46 million by 2032. The market in the country is projected to gross an absolute dollar opportunity of US$ 31 million during the forecast period, growing at a CAGR of 11.6%.
The market in South Korea is projected to witness an absolute dollar opportunity of US$ 9.6 million during the forecast period. By 2032, the market in the country is likely to reach US$ 17 million by 2032, growing at a CAGR of 8.5%.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Low-Frequency pulsed electromagnetic field therapy devices market is expected to account for the highest CAGR of 8.8%. Low-frequency PEMF devices generate magnetic fields with frequencies that are medium-high but low in intensity. These devices may also be used to address hard tissues and delayed bone growth. Low-frequency PEMF devices are used to treat rheumatoid arthritis inflammation, pain, and impairments in a quick, non-invasive, and simple way. As a result, the use of low-frequency PEMF therapy devices for arthritis treatment is likely to drive growth.
Some of the players operating in the pulse electromagnetic field therapy devices market include Bedfont Scientific, Orthofix Holdings, Nuage Health, Bemer, Oxford Medical Instruments Health, OSKA, Medithera, NiuDeSai, and I-Tech Medical Division.
Some of the recent developments of key players in the Pulse Electromagnetic Field Therapy Devices Market are as follows:
Similarly, recent developments related to companies offering Pulse Electromagnetic Field Therapy Devices Market have been tracked by the team at Future Market Insights, which is available in the full report.
The global Pulse Electromagnetic Field Therapy Devices Market is worth more than US$ 416.6 Million at present.
The value of the Pulse Electromagnetic Field Therapy Devices Market is projected to increase at a CAGR of around 8.6% during 2022 to 2032.
The value of the Pulse Electromagnetic Field Therapy Devices Market increased at a CAGR of around 7.8% from 2017 to 2021.
With a CAGR of 8.3% historically, Low-Frequency segment dominated the Pulse Electromagnetic Field Therapy Devices industry.
The top 5 countries driving demand for Pulse Electromagnetic Field Therapy Devices Market are the USA, the United Kingdom., China, Japan, and South Korea.
The Japanese market for Pulse Electromagnetic Field Therapy Devices is projected to expand at a CAGR of around 11.6% during 2022 to 2032.
While the market in South Korea is expected to grow at nearly 8.5%, the market in the United Kingdom is projected to register a CAGR of nearly 9.8% from 2022 to 2032.
1. Executive Summary| Pulse Electromagnetic Field Therapy Devices Market
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Market
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ million)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Market, by Key Countries
4.2. Market Opportunity Assessment (US$ million)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Patch Management Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Patch Management Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032
6.1. Historical Market Analysis, 2017 to 2021
6.2. Current and Future Market Projections, 2022 to 2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$ million) Analysis, 2017 to 2021
7.2. Current and Future Market Value (US$ million) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Component
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ million) Analysis By Component, 2017 to 2021
8.3. Current and Future Market Size (US$ million) Analysis and Forecast By Component, 2022 to 2032
8.3.1. Low Frequency
8.3.2. High Frequency
8.4. Market Attractiveness Analysis By Component
9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ million) Analysis By Application, 2017 to 2021
9.3. Current and Future Market Size (US$ million) Analysis and Forecast By Application, 2022 to 2032
9.3.1. Bone Growth
9.3.2. Pain Management
9.3.3. Other Applications
9.4. Market Attractiveness Analysis By Application
10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-use
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ million) Analysis By End-use, 2017 to 2021
10.3. Current and Future Market Size (US$ million) Analysis and Forecast By End-use, 2022 to 2032
10.3.1. Home Care Settings
10.3.2. Hospitals
10.3.3. Other End-uses
10.4. Market Attractiveness Analysis By End-use
11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ million) Analysis By Region, 2017 to 2021
11.3. Current Market Size (US$ million) & Analysis and Forecast By Region, 2022 to 2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. APAC
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
12.4.1. By Country
12.4.1.1. The USA
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By Component
12.4.3. By End-use
12.4.4. By Application
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Component
12.5.3. By End-use
12.5.4. By Application
13. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Component
13.4.3. By End-use
13.4.4. By Application
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Component
13.5.3. By End-use
13.5.4. By Application
14. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
14.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. The United Kingdom
14.4.1.4. Italy
14.4.1.5. Netherlands
14.4.1.6. Belgium
14.4.1.7. Rest of Europe
14.4.2. By Component
14.4.3. By End-use
14.4.4. By Application
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Component
14.5.3. By End-use
14.5.4. By Application
15. APAC Market Analysis 2017 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
15.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Rest of APAC
15.4.2. By Component
15.4.3. By End-use
15.4.4. By Application
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Component
15.5.3. By End-use
15.5.4. By Application
16. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
16.4. Market Size (US$ million) & Forecast By Market Taxonomy, 2022 to 2032
16.4.1. By Country
16.4.1.1. Saudi Arabia
16.4.1.2. South Africa
16.4.1.3. Nigeria
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Component
16.4.3. By End-use
16.4.4. By Application
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Component
16.5.3. By End-use
16.5.4. By Application
17. Key Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.2.2.1. By Component
17.2.2.2. By End-use
17.2.2.3. By Application
17.3. Canada Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.3.2.1. By Component
17.3.2.2. By End-use
17.3.2.3. By Application
17.4. Mexico Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.4.2.1. By Component
17.4.2.2. By End-use
17.4.2.3. By Application
17.5. Brazil Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.5.2.1. By Component
17.5.2.2. By End-use
17.5.2.3. By Application
17.6. Germany Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.6.2.1. By Component
17.6.2.2. By End-use
17.6.2.3. By Application
17.7. France Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.7.2.1. By Component
17.7.2.2. By End-use
17.7.2.3. By Application
17.8. Italy Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.8.2.1. By Component
17.8.2.2. By End-use
17.8.2.3. By Application
17.9. Netherlands Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.9.2.1. By Component
17.9.2.2. By End-use
17.9.2.3. By Application
17.10. United Kingdom Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.10.2.1. By Component
17.10.2.2. By End-use
17.10.2.3. By Application
17.11. Belgium Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.11.2.1. By Component
17.11.2.2. By End-use
17.11.2.3. By Application
17.12. China Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.12.2.1. By Component
17.12.2.2. By End-use
17.12.2.3. By Application
17.13. Japan Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.13.2.1. By Component
17.13.2.2. By End-use
17.13.2.3. By Application
17.14. South Korea Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.14.2.1. By Component
17.14.2.2. By End-use
17.14.2.3. By Application
17.15. Saudi Arabia Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.15.2.1. By Component
17.15.2.2. By End-use
17.15.2.3. By Application
17.16. South Africa Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.16.2.1. By Component
17.16.2.2. By End-use
17.16.2.3. By Application
17.17. Nigeria Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.17.2.1. By Component
17.17.2.2. By End-use
17.17.2.3. By Application
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Bedfont Scientific
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. Orthofix Holdings
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. Nuage Health
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. Bemer
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. Oxford Medical Instruments Health
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. OSKA
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Strategy Overview
19.3.7. Medithera
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Strategy Overview
19.3.8. NiuDeSai
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Strategy Overview
19.3.9. I-Tech Medical Division
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Sales Footprint
19.3.9.4. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Pulse Electromagnetic Field Therapy Devices Market
